NPI: 1881968774 · PHILADELPHIA, PA 19123 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/24/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/24/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,529 | $11K |
| 2020 | 2,700 | $165K |
| 2021 | 8,492 | $742K |
| 2022 | 8,732 | $1.07M |
| 2023 | 9,854 | $1.20M |
| 2024 | 7,046 | $867K |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,520 | 2,780 | $4.05M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,728 | 385 | $12K |
| 82728 | 526 | 493 | $0.00 | |
| 90674 | 13 | 13 | $0.00 | |
| 83550 | 534 | 497 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 1,341 | 650 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,071 | 267 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 40 | 35 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 78 | 40 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 14 | 14 | $0.00 |
| 83540 | 539 | 500 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 1,336 | 414 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 640 | 389 | $0.00 |
| 83970 | 519 | 499 | $0.00 | |
| 85041 | 429 | 406 | $0.00 | |
| 85048 | 430 | 406 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,571 | 222 | $0.00 |
| 82108 | 24 | 23 | $0.00 |